RERonald K. Elswick

Ronald K. Elswick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ronald K. Elswick has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protocol of Pilot Clinical Trial of the NEXt Generation Health Through 2D & 3D Fetal UltraSound; Building Connections to Support Maternal-fetal Health (NEXUS) (Preprint)

    by Amy L Salisbury, Courtney Holmes, Dace Svikis, Caitlin E Martin, Tara Cothren, Shannon E Cusack, Georgette Nelson, Lisa Burrington, Cotina Brake, Emily Smith, et al.

    BACKGROUND Substance use may increase risk for adverse health conditions and perinatal complications, and women with substance use disorder (SUD) have a disproportionately higher risk for maternal morbidity and mortality. Fetal ultrasound observations may create an opportunity to increase maternal attachment to the fetus, contributing to greater self-efficacy and self-care through sustained prenatal care and SUD treatment, ultimately improving health outcomes. OBJECTIVE This pilot sequential explanatory mixed-methods randomized controlled trial was designed to determine the feasibility, acceptability, and efficacy of a novel non-diagnostic fetal ultrasound protocol that promotes maternal-fetal connection in pregnant women with active SUD or high risk of SUD prior to 32 weeks of pregnancy by testing: (1) the feasibility and acceptability of the NEXt generation health through 2D & 3D fetal UltraSound (NEXUS) ultrasound intervention, (2) preliminary group effects on measures of prenatal visit and SUD treatment engagement, gestational age at entry to care, maternal mental health, reported substance use, obstetric outcomes, and maternal-fetal/infant attachment at baseline, two pregnancy visits, and two postpartum visits; and (3) additional factors related to the implementation of the comparator and the NEXUS intervention group activities. METHODS After completing baseline measures, participants were randomized to two ultrasound sessions in either a Comparator group (standardized fetal ultrasound sessions controlling for time and attention) or the NEXUS group (interactive fetal ultrasound enhanced with motivational dialogue focusing on fetal behaviors, fetal strengths, and the woman's role in supporting those strengths through self-care). Follow-up surveys and interviews were conducted through 12 weeks postpartum, and a standardized infant neurobehavioral examination was conducted at 6-8 weeks post-birth. RESULTS Funding began in August 2022, with community engagement efforts from January to May 2023 to understand community needs and gather stakeholder input on study integration. Participant enrollment occurred from June 2023 to June 2025. N=141 pregnant individuals were screened for study eligibility, n=122 (86.5%) met study inclusion criteria, n=64 (52.5% of eligible) ultimately enrolled, and n=56 (87.5% of enrolled) were randomized to a study group (n=28 in NEXUS group, 28 in comparator). Follow-up data were then collected for the remaining active participants. CONCLUSIONS This paper describes the protocol and enrollment statistics. This study has the potential to improve public health by investigating the feasibility and efficacy of an intervention combining motivational interviewing and ultrasound to promote maternal-fetal attachment and motivation for self-care in pregnant women at high risk for SUD. Findings will identify feasible and acceptable intervention components, provide initial efficacy data, and inform the application of this approach in clinical settings to enhance maternal and child health outcomes. CLINICALTRIAL Clinicaltrials.gov; NCT05814575

  • Open Access

    Using a Heuristic Tool to Improve Symptom Self-Management in Adolescents and Young Adults With Cancer: Protocol for a Randomized Controlled Trial

    by Suzanne Ameringer, Grace Hodges, R K Elswick Jr, Lauri Linder, Catherine Fiona Macpherson, Kristin Stegenga

    Background: Adolescents and young adults (AYAs) with cancer experience multiple distressing symptoms during treatment, yet few developmentally relevant resources have been developed to help them self-manage their symptoms. Empowering patients to have a more active role in self-management during cancer treatment may lessen their symptom severity and distress. Objective: The aim of this study is to test an intervention designed to improve symptom self-management, the Computerized Symptom Capture Tool (C-SCAT), by helping AYAs understand their unique symptom experience and discuss it with their health care providers. Methods: We are conducting a multisite, 2-group randomized controlled trial to evaluate the effects of the C-SCAT in improving symptom self-management versus usual care in 126 AYAs who are within the first 3 months of a cancer diagnosis and who are receiving chemotherapy. Participants are randomly assigned to either the C-SCAT intervention group or the usual care group. The primary aim is to determine the effects of the C-SCAT versus usual care on the primary outcomes of self-efficacy for symptom management and symptom self-management behaviors. The secondary aim is to examine the effects of the C-SCAT versus usual care on distal outcomes, including symptoms and quality of life. Participants complete measures of self-efficacy for symptom management, symptom self-management behaviors, symptom severity and distress, quality of life social function, and quality of life satisfaction of social function at baseline (time 0), immediately postintervention (time 1), and at follow-up 1 month later (time 2). Results: Recruitment started on January 4, 2024, at the first site, and all sites were open by May 1, 2024. Thus far, accrual has been set at 73% of the quarterly benchmark goal. Linear mixed effects models will be used to test for group differences across time for the primary and secondary aims. Conclusions: This randomized controlled trial is evaluating an innovative, point-of-care intervention designed to be used at a clinic visit with the provider to improve symptom self-management for AYAs with cancer.

  • Exploration of the psychometric properties of the EPDS-US, a validation study

    by Sara Wagner Moyer, Suzanne Ameringer, R.K. Elswick, Jaclyn D. Nunziato, Patricia Anne Kinser


  • Open Access

    Perceptions and Experiences of Hematopoietic Cell Transplantation Patients During the COVID-19 Pandemic

    by Lathika Mohanraj, R.K. Elswick, Molly Buch, Jennifer M. Knight, Jeanine Guidry


  • Life‐space mobility in dementia patients and family caregivers: A dyadic approach

    by Jane Chung, Jongwon Lee, Ronald K. Elswick

    Background and objective: Given that most dementia care is provided at home by family caregivers, caregivers’ health and outdoor activities may influence persons with dementia (PWDs)’ mobility. At the same time, PWDs’ functional deterioration and mobility changes might affect mobility behaviours in their caregivers. The aims of this pilot study were to examine the relationship of PWD’s life‐space mobility (LSM) with their caregiver's LSM and to investigate the role of caregiver and PWD characteristics in determining the level of LSM in both PWDs and caregivers.Design and method: A cross‐sectional survey was conducted with 26 caregivers providing dementia care at home. Caregivers were used as proxy for assessing sociodemographic, clinical and physical function in PWDs. Caregivers’ sociodemographic characteristics, LSM, social support, depressive symptoms, caregiving burden and preparedness for caregiving were measured.Results: The level of LSM in caregivers was correlated with the PWD’s LSM level. Caregivers who perceived high levels of social support and readiness for caregiving tended to report high levels of LSM. PWDs’ age and independence in instrumental activities of daily living were correlated with caregivers’ LSM.Conclusions: The study findings suggest that the caregiver's LSM influenced and was affected by the PWD’s LSM. This underscores the need for additional research that examines the role of caregivers’ psychosocial and physical health on PWDs’ mobility and the context of dementia care and its influences on how dementia care dyads decide and participate in mobility behaviours.Implications for practice: The findings of this pilot study will be helpful in identifying a target for interventions designed to delay the onset of mobility disability and maintain and improve social participation in PWDs. To minimise the effects of mobility limitations in PWDs, it is critical to examine their mobility issues from multilevel perspectives, including their caregiver's LSM levels and characteristics that have implications for both research and clinical practice.


  • Open Access

    Comparison of Low Back Pain Recovery and Persistence

    by Angela R. Starkweather, Debra E. Lyon, Patricia Kinser, Amy Heineman, Jamie L. Sturgill, Xiaoyan Deng, Umaporn Siangphoe, R. K. Elswick, Joel Greenspan, Susan G. Dorsey

    Background: Persistent low back pain is a significant problem worldwide. Early identification and treatment of individuals at high risk for persistent low back pain have been suggested as strategies to decrease the rate of disability associated with this condition. Purpose: To examine and compare demographic, pain-related, psychological, and somatosensory characteristics in a cohort of participants with acute low back pain who later went on to experience persistent low back pain or whose pain resolved within the first 6 weeks after initial onset. Methods: A descriptive study was conducted among men and women 18–50 years of age who had an acute episode of low back pain. Study questionnaires were administered to collect demographic information and measures of pain, coping, reactivity, mood, work history and satisfaction, and disability. A standardized protocol of quantitative sensory testing was performed on each participant at the painful area of their low back and at a remote site on their arm. Results: The sample consisted of 48 participants, of whom 19 went on to develop persistent low back pain and 29 resolved. Compared to the resolved group, the persistent low back pain group was significantly older and had a lower level of educational attainment, a higher body mass index, and higher mean “least” pain score on the Brief Pain Inventory–Short Form. Significantly higher thermal detection thresholds at the painful and remote sites as well as signs of central sensitivity differentiated the persistent pain group from the resolved group during the acute stage of low back pain.


  • Biobehavioral examination of fatigue across populations: Report from a P30 Center of Excellence

    by Debra Lyon, Nancy McCain, R.K. Elswick, Jamie Sturgill, Suzanne Ameringer, Nancy Jallo, Victoria Menzies, JoLynne Robins, Angela Starkweather, Jeanne Walter, et al.


  • Open Access

    149. Epigenetic Alterations and an Increased Frequency of Micronuclei in Women With Fibromyalgia

    by D. Lyon, V. Menzies, K. Archer, J.R. Brumelle, K.H. Jones, G. Gao, R.K. Elswick, T. York, C. Jackson-Cook

  • The Effect of Supplemental Dietary Fat on Plasma Cholesterol Levels in Lovastatin‐Treated Hypercholesterolemic Patients

    by James M. McKenney, Jack D. Proctor, Jackson T. Wright, Robert J. Kolinski, R.K. Elswick, Jean S. Coaker

    Study Objective. A validation study was conducted first to test assumptions about the effect of saturated and unsaturated dietary fat supplements. The second study was conducted to determine the effect on blood cholesterol levels of saturated and unsaturated fat supplements in patients who followed a low‐fat diet and were administered lovastatin.Design. Randomized, crossover design, with three periods in the first study and four in the second study, each lasting 6 weeks.Setting. Cholesterol Research Center.Patients. The first study evaluated adults with total cholesterol levels between 200 and 280 mg/dl (5.172 and 7.241 mmol/L). The second study included adults with low‐density lipoprotein (LDL) cholesterol levels above 160 mg/dl (4.138 mmol/L).Interventions. Fat supplements with either coconut or canola oil were delivered to patients in oatmeal‐raisin cookies.Measurements and Main Results. In the validation study, patients' mean prerandomization total cholesterol level of 222 mg/dl was reduced to 213 mg/dl with canola oil and increased to 233 mg/dl with coconut oil cookies (p=0.0038). In the second study the mean prerandomization total cholesterol level of 214 mg/dl was decreased to 199 mg/dl with canola oil and to 208 mg/dl with coconut oil cookies (p=0.2342). The LDL cholesterol levels changed in a similar fashion in both studies.Conclusions. Changes in total and LDL cholesterol levels in the validation study were expected based on established effects of saturated and unsaturated fatty acids, but changes in these levels in lovastatin‐cookie study were not expected. They could have occurred because lovastatin reversed the effect of saturated fats and enhanced the effect of unsaturated fats. Alternatively, they may have been due to enhanced bioavailability of lovastatin when administered with a high‐fat diet. These findings must be confirmed.